深圳诺普信作物科学股份有限公司公告 证券代码：002215 证券简称：诺普信 公告编号：2025-005 深圳诺普信作物科学股份有限公司 《2024年度董事会工作报告》详见《深圳诺普信作物科学股份有限公司2024 年年度报告》第三节"管理层讨论与分析"。 公司第六届董事会独立董事李常青先生、李晓东先生以及第七届董事会独立 董事徐佳先生、姜帆先生向董事会提交了独立董事述职报告，并将在公司2024 年年度股东大会上述职。具体内容详见2025年4月25日在巨潮资讯网 http://www.cninfo.com.cn披露的《独立董事2024年度述职报告》。 本报告需提交公司2024年年度股东大会审议。 三、会议以同意5票，反对0票，弃权0票，审议通过关于《深圳诺普信作物 科学股份有限公司2024年年度报告》和《深圳诺普信作物科学股份有限公司2024 年年度报告摘要》的议案。 第七届董事会第五次会议决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误 导性陈述或重大遗漏。 《深圳诺普信作物科学股份有限公司2024年年度报告》内容详见2025年4月 深圳诺普信作物科学股份有限公司（以下简称"公司 ...

深圳诺普信作物科学股份有限公司公告 特别提示： 2024年度现金分红方案不触及《深圳证券交易所股票上市规则》第9.8.1 条规定的可能被实施其他风险警示情形。 一、审议程序 深圳诺普信作物科学股份有限公司（以下简称"公司"）于2025年4月23 日召开第七届董事会第五次会议及第七届监事会第四次会议，会议审议通过了 证券代码：002215 证券简称：诺普信 公告编号：2025-010 深圳诺普信作物科学股份有限公司 关于 2024 年度利润分配预案的公告 本公司及董事会保证公告内容真实、准确和完整，没有虚假记载、误导性陈 述或者重大遗漏。 1 深圳诺普信作物科学股份有限公司公告 如因限制性股票回购注销等原因致使分红对应的股份基数发生变动，最终以 利润分配股权登记日实际分配的股份基数进行现金分红，分配比例不变。 三、现金分红方案的具体情况 公司 2024 年度分红方案不触及其他风险警示情形 | 项目 | 本年度 | 上年度 | 上上年度 | | --- | --- | --- | --- | | 现金分红总额（元） | 351,816,958.50 | 151,875,139.05 | 149,256,214.0 ...

证券代码：002215 证券简称：诺普信 公告编号：2025-016 深圳诺普信作物科学股份有限公司 关于2023年限制性股票激励计划回购注销已不符合激励条件 激励对象已获授但尚未解锁的限制性股票的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误 导性陈述或重大遗漏。 深圳诺普信作物科学股份有限公司（以下简称"公司"）2025年4月23日召开 了第七届董事会第五次会议和第七届监事会第四次会议，会议审议通过了《关于 2023年限制性股票激励计划回购注销已不符合激励条件激励对象已获授但尚未 解锁的限制性股票的议案》。公司2023年限制性股票激励计划原激励对象李志刚、 袁绍孔等12人于2025年4月15日前因个人原因已离职；根据《公司2023年限制性 股票激励计划（草案）及其摘要》的相关规定，上述人员已不符合激励对象的条 件，其所持有的370,000股限制性股票将全部由公司回购注销。具体情况如下： 一、2023年限制性股票激励计划简述 深圳诺普信作物科学股份有限公司公告 1、2023年11月16日，公司召开第六届董事会第二十一次会议（临时），审 议并通过了《关于公司2023年限制性股票激励 ...

深圳诺普信作物科学股份有限公司 内部控制审计报告 政旦志远内字第 2500023 号 政旦志远（深圳）会计师事务所（特殊普通合伙） Zandar Certified Public Accountants LLP 深圳诺普信作物科学股份有限公司 内部控制审计报告 （截止 2024 年 12 月 31 日） 目 录 页 次 一、 内部控制审计报告 1-2 地址：深圳市福田区鹏程一路广电金融中心11F 电话：+86-755-88605026 www.zdcpa.com 内 部 控 制 审 计 报 告 政旦志远内字第 2500023 号 深圳诺普信作物科学股份有限公司全体股东： 按照《企业内部控制审计指引》及中国注册会计师执业准则的相 关要求，我们审计了深圳诺普信作物科学股份有限公司（以下简称深 圳诺普信公司）2024 年 12 月 31 日的财务报告内部控制的有效性。 一、企业对内部控制的责任 我们的责任是在实施审计工作的基础上，对财务报告内部控制的 有效性发表审计意见，并对注意到的非财务报告内部控制的重大缺陷 进行披露。 三、内部控制的固有局限性 内部控制具有固有局限性，存在不能防止和发现错报的可能性。 此外，由 ...

之 国浩律师（深圳）事务所 关 于 深圳诺普信作物科学股份有限公司 2023 年限制性股票激励计划回购注销部分 限制性股票相关事项 法律意见书 深圳市福田区深南大道 6008 号特区报业大厦 42、41、31DE、2403、2405 电话（Tel.）：(+86)(755)8351 5666 传真（Fax.）：(+86)(755)8351 5333/8351 5090 网站（Website）：http://www.grandall.com.cn 2025 年 4 月 法律意见书 释 义 除非另有说明，本法律意见书中相关词语具有以下特定含义： | 公司、诺普信 | 指 | 深圳诺普信作物科学股份有限公司 | | --- | --- | --- | | 《股票激励计划》 | 指 | 《深圳诺普信作物科学股份有限公司2023年限制性股 | | | | 票激励计划》 | | 本次激励计划 | 指 | 公司2023年限制性股票激励计划 | | 限制性股票 | 指 | 根据《股票激励计划》，激励对象被授予的存在限制 | | | | 性条件的公司股票 | | 《公司章程》 | 指 | 《深圳诺普信作物科学股份有限公司章程》 ...

中信建投证券股份有限公司 关于深圳诺普信作物科学股份有限公司 2024年度募集资金存放与使用情况的专项核查报告 中信建投证券股份有限公司（以下简称"中信建投证券"或"本保荐机构"）作 为深圳诺普信作物科学股份有限公司（以下简称"诺普信"或"公司"）非公开发行 股票的保荐机构，根据《证券发行上市保荐业务管理办法》、《深圳证券交易所股 票上市规则》和《深圳证券交易所上市公司自律监管指引第 13 号——保荐业务》 及《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》等 有关规定，对诺普信 2024 年度募集资金存放与使用情况进行了核查，发表如下 核查意见： 一、公司非公开发行股票募集资金情况 （一）募集资金到位情况 公司根据中国证券监督管理委员会出具的《关于核准深圳诺普信农化股份有 限公司非公开发行股票的批复》（证监许可[2021]19 号），以非公开发行股票 的方式向特定投资者共计发行 73,529,411 股人民币普通股（A 股），发行价格 为 4.76 元/股。本次非公开发行募集资金总额为人民币 349,999,996.36 元，扣 除与发行有关费用（不含税）人民币 5,688,084.7 ...

深圳诺普信作物科学股份有限公司 募集资金存放与使用情况鉴证报告 政旦志远核字第 2500092 号 | | 目 录 | | 页 | 次 | | --- | --- | --- | --- | --- | | 一、 | 募集资金存放与使用情况鉴证报告 | | 1-2 | | | 二、 | 深圳诺普信作物科学股份有限公司 | 2024 年度 | 1-5 | | | | 募集资金存放与使用情况的专项报告 | | | | 地址：深圳市福田区鹏程一路广电金融中心 11F 电话：+86-755-88605026 www.zdcpa.com 募 集 资 金 存 放 与 使 用 情 况 鉴 证 报 告 政旦志远（深圳）会计师事务所（特殊普通合伙） Zandar Certified Public Accountants LLP 深圳诺普信作物科学股份有限公司 募集资金存放与使用情况鉴证报告 （2024 年度） 深圳诺普信公司董事会的责任是按照中国证券监督管理委员会 《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监 管要求（2022 年修订）》、深圳证券交易所发布的《深圳证券交易所 上市公司自律监管指引第 1 号— ...

深圳诺普信作物科学股份有限公司 控股股东及其他关联方资金占用情况的 专项说明 政旦志远核字第 2500093 号 政旦志远（深圳）会计师事务所（特殊普通合伙） Zandar Certified Public Accountants LLP 深圳诺普信作物科学股份有限公司 控股股东及其他关联方资金占用情况的专项说明 （截止 2024 年 12 月 31 日） 目 录 页 次 一、 控股股东及其他关联方资金占用情况的专项 说明 1-2 二、 深圳诺普信作物科学股份有限公司 2024 年度 非经营性资金占用及其他关联资金往来情况 汇总表 1-3 地 址：深圳市福田区鹏程一路广电金融中心11F 电 话：+86-755-88605026 www.zdcpa.com 控 股 股 东 及 其 他 关 联 方 资 金 占 用 情 况 的 专 项 说 明 政旦志远核字第 2500093 号 深圳诺普信作物科学股份有限公司全体股东： 我们接受委托，依据《中国注册会计师执业准则》审计了深圳诺普 信作物科学股份有限公司（以下简称深圳诺普信公司）2024 年度财务 报表，包括 2024 年 12 月 31 日的合并及母公司资产负债表， ...

Financial Performance - The company's revenue for Q1 2025 reached ¥2,101,217,371.49, representing a 15.01% increase compared to ¥1,826,962,263.49 in the same period last year[6]. - Net profit attributable to shareholders was ¥626,925,211.01, a 37.99% increase from ¥454,314,295.21 year-on-year[6]. - Basic earnings per share rose to ¥0.6398, reflecting a 39.66% increase from ¥0.4581 in the same period last year[6]. - Operating profit for the current period was ¥647,929,041.63, up 44% from ¥451,244,724.87 in the previous period[28]. - Net profit attributable to the parent company was ¥626,925,211.01, representing a 38% increase from ¥454,314,295.21 in the previous period[28]. - Earnings per share (basic) increased to 0.6398 from 0.4581, reflecting a growth of 39.5%[29]. Assets and Liabilities - Total assets at the end of Q1 2025 were ¥12,026,330,736.67, a 7.09% increase from ¥11,229,976,236.79 at the end of the previous year[6]. - The company's equity attributable to shareholders increased by 16.52% to ¥4,464,585,012.61 from ¥3,831,480,194.32 at the end of the previous year[6]. - Current assets totaled CNY 4,683,638,016.55, up from CNY 4,519,318,182.93, indicating a growth of approximately 3.64%[23]. - Total liabilities amounted to CNY 7,320,120,543.94, compared to CNY 7,150,788,327.75 at the beginning of the period, marking an increase of approximately 2.37%[24]. - Non-current liabilities totaled CNY 1,911,926,545.03, up from CNY 1,699,052,125.86, reflecting an increase of approximately 12.48%[24]. Cash Flow - The net cash flow from operating activities decreased by 38.53% to ¥270,472,560.32, down from ¥439,983,306.19 in the previous year[6]. - Cash flow from operating activities generated a net amount of ¥270,472,560.32, down 38% from ¥439,983,306.19 in the previous period[31]. - The net cash flow from investing activities was -$304.39 million, slightly improved from -$305.44 million in the previous period[33]. - The net cash flow from financing activities was -$52.37 million, a decline from a positive $118.72 million last year[33]. - The net increase in cash and cash equivalents was -$86.24 million, contrasting with a positive increase of $253.28 million in the previous year[33]. - The ending balance of cash and cash equivalents was $723.31 million, down from $1.06 billion at the end of the previous period[33]. Sales and Revenue Drivers - The increase in revenue was driven by a ¥160 million increase in fresh consumption business sales, growing by 16.94%, and a ¥124 million increase in pesticide formulation sales, growing by 17.16%[14]. - The company reported a significant increase in accounts receivable, which rose by 94.67% to ¥100,702.31 million, primarily due to seasonal sales increases[12]. - The company has shown a significant increase in accounts receivable, which may indicate improved sales performance or changes in credit policy[22]. Expenses - Research and development expenses were ¥29,895,585.05, a decrease of 14% compared to ¥34,817,351.53 in the previous period[28]. - The company reported a decrease in sales expenses to ¥162,037,573.23 from ¥168,147,437.87, a reduction of about 3%[28]. Future Plans and Changes - The company plans to continue expanding its fresh consumption blueberry business, which has shown significant growth in sales volume[12]. - The company did not undergo an audit for the first quarter report[34]. - The new accounting standards will be first implemented starting in 2025[34].

Financial Performance - The company's operating revenue for 2024 reached ¥5,288,197,241.74, an increase of 28.37% compared to ¥4,119,537,885.40 in 2023[15] - Net profit attributable to shareholders surged by 148.10% to ¥584,590,497.99 from ¥235,626,547.17 in the previous year[15] - The net profit after deducting non-recurring gains and losses increased by 167.68% to ¥511,132,288.63, compared to ¥190,946,531.77 in 2023[15] - The cash flow from operating activities improved significantly, totaling ¥1,305,652,295.51, a 104.09% increase from ¥639,748,333.74 in 2023[15] - Basic earnings per share rose to ¥0.5869, reflecting a 143.63% increase from ¥0.2409 in the previous year[15] - Total assets at the end of 2024 amounted to ¥11,229,976,236.79, a 3.33% increase from ¥10,867,931,839.75 in 2023[15] - Total revenue for 2024 reached ¥5,288,197,241.74, representing a 28.37% increase from ¥4,119,537,885.40 in 2023[56] - Fresh consumption business revenue surged to ¥2,139,163,680.37, a remarkable growth of 251.28% compared to ¥608,966,362.55 in the previous year[56] - The pesticide formulation business generated ¥2,312,778,439.25, a decrease of 4.46% from ¥2,420,724,286.95 in 2023[56] Strategic Focus - The company is focusing on the blueberry market as a strategic growth area, aiming to enhance planting levels and brand development for its blueberry products[30] - The company has established a comprehensive quality management system and supply capabilities to support its blueberry business, targeting major retail clients and expanding into first, second, and third-tier cities[30] - The company is implementing a strategy of integrating agricultural science and technology to enhance production efficiency and develop a comprehensive service system for agricultural production[28] - The company is leveraging new media platforms for marketing, enhancing the quality and quantity of service to large farmers through innovative promotional strategies[32] - The company is committed to a brand strategy centered around a major product/solution, aiming to strengthen its service capabilities for large farmers[31] Production and Capacity - The insecticide production capacity is 27,900 tons/year with a utilization rate of 74.70%, while the fungicide capacity is 18,000 tons/year with a 60.00% utilization rate[36] - The herbicide production capacity is 25,000 tons/year, currently under construction with an additional 1,000 tons/year planned[36] - The company has achieved a 73.88% increase in production capacity through the automation upgrades[1] - The company has successfully upgraded its production lines and completed new construction projects, enhancing operational efficiency[1] Research and Development - Research and development investment reached ¥150,352,410.27, a 22.80% increase from the previous year, with R&D expenditure accounting for 2.84% of operating revenue[68] - The number of R&D personnel increased by 29.33% to 269, with a notable rise in younger employees aged under 30[68] - A total of 14 new products were registered, and 347 projects for new compounds and conventional products were approved for development[51] - The company is actively involved in the development of new herbicides and fungicides, including innovative formulations and application methods[36] Environmental Compliance - The company has complied with various environmental protection laws and regulations, ensuring legal and regulatory compliance in its operations[186] - The company has established comprehensive waste treatment facilities to minimize negative environmental impacts during production[186] - The company received a renewed pollutant discharge permit valid until December 10, 2029, reflecting ongoing compliance with environmental standards[187] - The company is actively monitoring and evaluating new environmental regulations to ensure compliance in its production processes[186] - The company has not faced any administrative penalties from environmental authorities at any level in 2024, indicating strong compliance with environmental regulations[192] Governance and Management - The board of directors consists of 5 members, including 2 independent directors, ensuring compliance with governance standards[119] - The supervisory board is composed of 3 members, with a focus on overseeing financial reports and major investment decisions to protect shareholder interests[120] - The company has implemented a management structure that adheres to the company's articles of association and ensures no internal control issues exist[120] - The company has established a market value management system to protect the interests of stakeholders and enhance transparency in information disclosure[113] - The company maintains a high level of information disclosure and transparency, ensuring all shareholders have equal access to relevant information[122] Employee Development - The total number of employees at the end of the reporting period is 5,116, with 303 in the parent company and 4,713 in major subsidiaries[156] - The professional composition includes 1,905 production personnel, 2,008 sales personnel, 303 technical personnel, 261 financial personnel, and 639 administrative personnel[157] - The company implements a salary policy that emphasizes "performance-based" compensation, with different models for senior management, sales personnel, and other employees[158] - Training programs are organized for new employees, covering industry knowledge, corporate culture, and professional skills, with online platforms for continuous learning[159] Shareholder Engagement - The company held several shareholder meetings in 2024, with participation rates of 34.02%, 35.56%, 34.92%, 39.98%, and 34.26% respectively[126] - The company has actively engaged with institutional investors through multiple communication channels, including phone conferences and online meetings[112] - The company has established a robust organizational structure that operates independently, enhancing operational efficiency[125] Financial Management - The company plans to distribute a cash dividend of ¥3.5 per 10 shares, based on a total share capital of 1,005,191,310 shares[4] - The company has completed the use of all raised funds by the end of 2024, with total interest and investment income from the fundraising account amounting to ¥476,979.06 during the reporting period[89] - The company has not reported any issues or problems regarding the use and disclosure of raised funds[92] - The company has a plan for future stock grants based on performance metrics[128] Challenges and Risks - The company continues to face challenges in attracting and retaining talented professionals, emphasizing the importance of management capabilities and operational levels[109] - The company has a clear strategy for addressing risks related to agricultural product price volatility and raw material supply chain disruptions[110][111]